We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase 2 Trials Underway for New Single Dose Malaria Treatment

News   Aug 12, 2015

 
Phase 2 Trials Underway for New Single Dose Malaria Treatment
 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

A Third "Short Sleep" Gene Has Been Discovered – And It Prevents Memory Deficits

News

In a new study, scientists have discovered a third "short sleep" gene. It is the first gene to be identified that prevents the memory deficits typically associated with sleep deprivation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE